ADMA ADMA Biologics
- 10.630
- -0.150-1.39%
- 10.800
- +0.170+1.60%
ADMA Biologics News
Form 144 | ADMA Biologics(ADMA.US) Officer Proposes to Sell 5.25 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $ADMA Biologics(ADMA.US)$ Officer Grossman Adam S intends to sell 500K shares of its common stock on Jun 14, with a total market value of approximately $5.25 million.
Catalyst Watch: HP Enterprise Event, Walmart+ Week, Pure Storage Buzz, and Triple-witching Volatility
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin) Insights & Forecast 2024-2028, Featuring CSL, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion & ADMA Biologics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ResearchAndMarkets.com's o
An Intrinsic Calculation For ADMA Biologics, Inc. (NASDAQ:ADMA) Suggests It's 36% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, ADMA Biologics fair value estimate is US$16.48 ADMA Biologics' US$10.58 share price signals that it might be 36% undervalued The US$10.50
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Share Price Boosted 53% But Its Business Prospects Need A Lift Too
Despite an already strong run, ADMA Biologics, Inc. (NASDAQ:ADMA) shares have been powering on, with a gain of 53% in the last thirty days.
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
ADMA Biologics First Quarter 2024 Earnings: Beats Expectations
ADMA Biologics Hits 52-week High on Q1 Beat, Guidance Raise
ADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024
ADMA Biologics Price Target Raised to $10.00/Share From $8.00 by Raymond James
ADMA Biologics Price Target Raised to $10.00/Share From $8.00 by Raymond James
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Diodes posted adjusted earnings of 28 cents
Express News | Cantor Fitzgerald Maintains Overweight on ADMA Biologics, Raises Price Target to $10
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday.
ADMA Biologics Up Over 24%, on Track for Highest Close Since December 2015 -- Data Talk
ADMA Biologics, Inc. (ADMA) is currently at $8.62, up $1.70 or 24.46% --Would be highest close since Dec. 14, 2015, when it closed at $8.63 --On pace for largest percent increase since Nov. 10, 2022
Novavax, Macrogenics, Biofrontera Among Healthcare Movers
Earnings Call Summary | ADMA Biologics(ADMA.US) Q1 2024 Earnings Conference
The following is a summary of the ADMA Biologics, Inc. (ADMA) Q1 2024 Earnings Call Transcript:Financial Performance:ADMA Biologics reported a Q1 2024 revenue of $81.9 million, indicating an increase
ADMA Biologics Is Maintained at Buy by Mizuho
ADMA Biologics Is Maintained at Buy by Mizuho
ADMA Biologics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 51.9% Mizuho $10 → $12 Maintains Buy 03/26/2024 -5.06% HC Wainwright & Co. $6 → $7.5 Reiterates
Express News | ADMA Biologics Inc : Mizuho Raises Target Price to $12 From $10
Strong Financial Performance and Growth Prospects Affirm Buy Rating for ADMA Biologics
Analysis
Price Target
No Data
